PinkDx
INDIANAPOLIS, IN · Biotechnology · 18 employees
PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive impact on their lives. The company's first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological c
Funding history
- Series series a — $5.0M — Jan 2025
- Series series a — $40.0M — Apr 2024
Recent signals
- Jan 24, 2025: Raised $5.0M in Series series a
- Nov 04, 2024: PinkDx Appoints Marra S. Francis, M.D., F.A.C.O.G., as Chief Medical Officer
- Apr 25, 2024: Raised $40.0M in Series series a
See plans & pricing → Track PinkDx’s funding, hiring, and signals — with verified contacts — on Fundz.